Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited)

v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenues $ 5,604 $ 3,579 $ 9,619 $ 6,970
Cost of revenues 3,484 2,218 6,035 4,303
Gross profit 2,120 1,361 3,584 2,667
Operating expenses:        
Research and development 575 506 1,169 976
Selling, general and administrative 1,882 1,705 3,847 3,714
Total operating expenses 2,457 2,211 5,016 4,690
Loss from operations (337) (850) (1,432) (2,023)
Other (expense) income, net (394) 387 (541) 563
Net loss before income taxes (731) (463) (1,973) (1,460)
Income tax benefit (expense) 197 (147) 198 (293)
Net loss $ (534) $ (610) $ (1,775) $ (1,753)
Net loss per share: basic $ (0.32) $ (0.59) $ (1.08) $ (1.86)
Net loss per share: diluted $ (0.32) $ (0.59) $ (1.08) $ (1.86)
Weighted-average number of shares outstanding: basic 1,646 1,034 1,643 943
Weighted-average number of shares outstanding: diluted 1,646 1,034 1,643 943
Other comprehensive loss:        
Net loss $ (534) $ (610) $ (1,775) $ (1,753)
Foreign currency translation adjustments 205 (593) 1,011 (1,474)
Comprehensive loss $ (329) $ (1,203) $ (764) $ (3,227)